BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1105868)

  • 21. Evaluation of terguride in patients with Parkinson's disease.
    Suchy I; Rinne UK; Wachtel H
    Adv Neurol; 1987; 45():577-81. PubMed ID: 3548267
    [No Abstract]   [Full Text] [Related]  

  • 22. Bromocriptine and lisuride in Parkinson's disease.
    Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
    Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of biperiden in delayed-release form in the treatment of Parkinson's disease and parkinsonian syndromes of various etiologies. Clinical experiments].
    Puntoni U
    Clin Ter; 1983 Oct; 107(1):37-44. PubMed ID: 6653070
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with a new muscle relaxant (DS 103-282 Sandoz) (author's transl)].
    Ringwald E; Campean SJ; Gerstenbrand F; Lorincz A; Lörincz P; Ludin HP
    Nervenarzt; 1977 Jul; 48(7):355-8. PubMed ID: 333301
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lisuride in Parkinson disease].
    Leiguarda R; Micheli F; Fernández Pardal M
    Medicina (B Aires); 1985; 45(1):29-34. PubMed ID: 3880105
    [No Abstract]   [Full Text] [Related]  

  • 26. [Combination of L-dopa and sulpiride in the treatment of Parkinson's disease].
    Brion S; Guérin R
    Cah Med; 1973 Jul; 14(8):695-8. PubMed ID: 4602472
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
    Lieberman AN; Neophytides A; Leibowitz M; Gopinathan G; Pact V; Walker R; Goodgold A; Goldstein M
    Adv Neurol; 1983; 37():95-108. PubMed ID: 6858782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Huntington's chorea with bromocriptine.
    Frattola L; Albiazzati MG; Spano PF; Trabucchi M
    Acta Neurol Scand; 1977 Jul; 56(1):37-45. PubMed ID: 141860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polygraphic evaluation of a new vasoactive drug (nicergoline)].
    Baturic P; Cirignotta F
    Minerva Cardioangiol; 1973 Oct; 21(10):664-7. PubMed ID: 4589189
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experience with the use of parlodel in the treatment of Parkinson patients].
    Stoliarova LG; Kadykov AS; Shvedkov VV; Pivovarova VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):219-22. PubMed ID: 3705825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bromocriptin in Parkinson's syndrome].
    Völler GW; Ulm G
    Med Welt; 1979 Dec; 30(51-52):1930-3. PubMed ID: 542110
    [No Abstract]   [Full Text] [Related]  

  • 32. Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
    Prescrire Int; 2000 Feb; 9(45):195-7. PubMed ID: 11503793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pergolide treatment in parkinsonism.
    Ilson J; Fahn S; Mayeux R; Cote LJ; Snider SR
    Adv Neurol; 1983; 37():85-94. PubMed ID: 6858780
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative efficacy of two dopamine agonists, pergolide and lergotrile, in Parkinson disease.
    Lieberman AN; Goldstein M; Leibowitz M
    N Y State J Med; 1988 Aug; 88(8):420-2. PubMed ID: 2902541
    [No Abstract]   [Full Text] [Related]  

  • 35. Lisuride and pergolide in Parkinson's disease.
    Lang AE; Sheehy MP; Quinn NP; Brincat S; Marsden CD; Parkes D
    Adv Neurol; 1983; 37():109-20. PubMed ID: 6858769
    [No Abstract]   [Full Text] [Related]  

  • 36. Lisuride in parkinsonism.
    Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Parkinsonian syndrome caused by carbon monoxide poisoning. Preliminary results of the treatment with bromocriptine].
    De Pooter MC; Leys D; Godefroy O; De Reuck J; Petit H
    Rev Neurol (Paris); 1991; 147(5):399-403. PubMed ID: 1853038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Parlodel: a new therapeutic possibility in the management of Parkinson disease].
    Glaub T; Berecz G; Pintér N; Diószeghy P; Virga A; Mechler F
    Orv Hetil; 1988 Feb; 129(8):399-402. PubMed ID: 3279375
    [No Abstract]   [Full Text] [Related]  

  • 40. Current concepts in drug therapy. (21) Bromocriptine "Parlodel" (Sandoz).
    Lionel ND
    Ceylon Med J; 1976 Jun; 21(2):152-5. PubMed ID: 1037381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.